ArticleHaematologica2016

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08).

Christoph Driessen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.